← Back to All Filings

Aramark (ARMK) Director Receives Routine Stock Grant

Low SignificanceDecember 18, 2025 at 5:35:30 PM EST

Aramark

$ARMK4CIK: 0001584509

Subscribe to track ARMK

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Aramark (ARMK) Director Receives Routine Stock Grant

Company: Aramark (ARMK) Form: 4 | Filed: 2025-12-18 Significance: Low

Insider: CAMERON SUSAN M. Title: null | Relationship: Director

Transaction: • Type: Grant • Shares: 136.134 • Price: $0.00 • Value: $0 • Owned After: 42,961.657

Key Insight: This is a minor, non-cash transaction representing dividend equivalent rights, a routine form of director compensation with no immediate market impact.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Aramark (ARMK)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director received a small, zero-cost grant of 136 shares as dividend equivalent rights, a routine compensation event with no market value.
  • Market Impact: Negligible. This is a non-market transaction with a total value of $0.

Company Information

FieldValue
CompanyAramark
Ticker SymbolARMK
CIK0001584509
IndustryRETAIL-EATING PLACES [5812]

Insider Information

FieldValue
NameCAMERON SUSAN M.
CIK0001297075
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-17
Transaction CodeA
Security TypeCommon Stock
Shares Involved136.134
Price Per Share$0.00
Total Value$0
Shares Owned After42961.657
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted136.134
% of Shares OutstandingNot available
Post-Transaction Ownership42,961.657 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction has a value of $0 and is therefore insignificant against Aramark's $10.00 billion market capitalization.
  • Transaction Significance: This is a routine, non-cash award of dividend equivalent rights, as noted in the filing's footnotes. It does not represent an open market purchase or a discretionary investment decision by the insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a pre-scheduled, zero-value grant related to dividends. It carries no new information about the company's performance or the insider's sentiment.

Volume & Sentiment

  • Expected Volume Impact: None. This was not an open-market transaction.
  • Sentiment Indicator: Neutral. This type of filing is a standard part of corporate governance and compensation and does not signal any bullish or bearish sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote clarifies that these shares are "dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person." This confirms the routine and non-discretionary nature of the transaction.
Topics:#Aramark#ARMK#SECFiling#Form4#InsiderTrading#StockGrant#Director#Investing#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.